COMMUNIQUÉS West-GlobeNewswire

Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial
01/12/2025
Vancouver, Canada, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Junction Brain Health Opens Toledo Clinic
01/12/2025
TOLEDO, Ohio, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Junction Brain Health, a leading provider of advanced, non-invasive treatments for depression and related conditions, announced today the opening of its new clinic in [...]
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
01/12/2025
PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, [...]
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
01/12/2025
Reimbursement milestone marks a key stride in improving patient access to advanced lymphedema treatment nationwide JACKSONVILLE, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics [...]
Alpha Tau to Participate in December Investor Conferences
01/12/2025
JERUSALEM, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration
01/12/2025
Management to Participate in 8th Annual Evercore Annual Healthcare Conference NESS ZIONA, Israel, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical [...]
NRG Therapeutics Announces Further Expansion with the Appointment of Paul Thompson as Chief Development Officer
01/12/2025
STEVENAGE, United Kingdom, Dec. 01, 2025 (GLOBE NEWSWIRE) -- NRG Therapeutics Ltd. (“NRG”), an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is pleased to announce [...]
Rakovina Therapeutics Announces Three-Month Q3 ended September 30, 2025 Financial Results and Provides Corporate Update
01/12/2025
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0 [...]
Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025
01/12/2025
GUANGZHOU, China, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “ Company ” or “ Burning Rock ”), a company focusing on the application of next generation sequencing (NGS) technology [...]
DeepHealth Launches Breast Suite, Elevating Breast Cancer Detection, Risk Stratification and Workflow
01/12/2025
Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates, 1 risk [...]
New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease
01/12/2025
Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in a global Phase 3 trial for Stargardt disease, achieving a statistically significant p-value of 0.0033 Tinlarebant met the primary [...]
Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing to Fund Development of Its Innovative Pipeline
01/12/2025
Financing co-led by NovaCapital, private high-net-worth individuals and members of Club Degli Investitori BRIDGEWATER, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Juniper Biosciences LLC today announced the closing of an [...]
Ipsen annonce avec une profonde tristesse le décès de Henri Beaufour, membre de son conseil d'administration issu de la famille fondatrice
01/12/2025
PARIS, FRANCE, LE 1ER DECEMBRE 2025 - C’est avec une immense émotion qu'Ipsen (Euronext : IPN ; ADR : IPSEY) annonce le décès de Henri Beaufour, membre du conseil d'administration et représentant de la famille [...]
Ipsen mourns the passing of Henri Beaufour, a founding family Board member
01/12/2025
PARIS, FRANCE, 1 DECEMBER 2025 - It is with great sadness that Ipsen (Euronext: IPN; ADR: IPSEY) today announces that Henri Beaufour, Ipsen Board Member and a representative of the founding family, passed away on Friday [...]
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025
01/12/2025
Geneva, Switzerland, December 1, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for [...]
Opterion Health AG Announces Appointment of Andreas Schuh as Chief Financial Officer
01/12/2025
MUTTENZ, Switzerland, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company pioneering innovation in peritoneal dialysis (PD), is pleased to announce the appointment of Andreas [...]
Clue Unveils Our Year In Cycles: A Candid Look at How We Bled, Felt, Loved and Lived in 2025
01/12/2025
Exclusive cycle tracking data reveals 280 million days of bleeding were tracked across the globe in the last 12 months App users logged 34 million sex sessions and 4.4 million orgasms across 2025 44.6 million days of [...]
Clue Unveils Our Year In Cycles: A Candid Look at How We Bled, Felt, Loved and Lived in 2025
01/12/2025
Exclusive cycle tracking data reveals 280 million days of bleeding were tracked across the globe in the last 12 months App users logged 34 million sex sessions and 4.4 million orgasms across 2025 44.6 million days of [...]
Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform
30/11/2025
November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – Royal Philips (NYSE [...]

Pages